Viewing Study NCT00517218

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:58 AM
Ignite Modification Date: 2025-12-26 @ 3:59 AM
Study NCT ID: NCT00517218
Status: WITHDRAWN
Last Update Posted: 2008-02-11
First Post: 2007-08-14
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: This Study is Being Performed to Evaluate the Effect of Genasense on the Efficacy and the Safety of Rituximab/Fludarabine Combination Treatment in Previously Untreated Subjects With Chronic Lymphocyctic Leukemia(CLL)
Sponsor: Genta Incorporated
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphocytic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Evaluate the Effect of Genasense on the Efficacy/Safety of Rituximab/Fludarabine … View